XML 60 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Tables)
3 Months Ended
Jun. 28, 2013
Stock-based Compensation [Abstract]  
Schedule Of Stock-Based Compensation Expense Recognized In Our Condensed Consolidated Statements Of Income

 

 

 

 

 

Three Months Ended

 

June 28,

 

June 29,

 

2013

 

2012

 

(In millions, except per share data)

Cost of revenue 

$                      4

 

$                      4

Sales and marketing

14 

 

16 

Research and development

13 

 

11 

General and administrative

 

Total stock-based compensation expense

39 

 

38 

Tax benefit associated with stock-based compensation expense

(11)

 

(10)

Net stock-based compensation expense

$                    28

 

$                    28

Net stock-based compensation expense per share attributable to Symantec Corporation stockholders— basic

$                 0.04

 

$                 0.04

Net stock-based compensation expense per share attributable to Symantec Corporation stockholders— diluted

$                 0.04

 

$                 0.04

 

Schedule Of Stock-Based Compensation Arrangements By Stock-Based Payment Award

 

 

 

 

 

Three Months Ended

 

June 28,

 

June 29,

 

2013

 

2012

 

($ in millions, except per grant data)

Restricted stock

 

 

 

Weighted-average fair value per grant

$                23.86

 

$                14.95

Fair value of awards granted

45 

 

134 

Total fair value of awards vested

74 

 

26 

Total unrecognized compensation expense

224 

 

292 

Weighted-average remaining vesting period

3 years

 

3 years

Performance-based restricted stock

 

 

 

Weighted-average fair value per grant

$                19.04

 

$                16.60

Fair value of awards granted

33 

 

21 

Total fair value of awards vested

11 

 

 -

Total unrecognized compensation expense

40 

 

28 

Weighted-average remaining vesting period

2 years

 

2 years

Stock options

 

 

 

Weighted-average fair value per grant

$                        -

 

$                  4.07

Total intrinsic value of stock options exercised

21 

 

Total unrecognized compensation expense

11 

 

26 

Weighted-average remaining vesting period

2 years

 

2 years